GeneDx Holdings Stock Forecast - Simple Exponential Smoothing
| WGS Stock | 104.88 3.53 3.48% |
GeneDx Stock outlook is based on your current time horizon.
At this time, the value of RSI of GeneDx Holdings' share price is approaching 35. This entails that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling GeneDx Holdings, making its price go up or down. Momentum 35
Sell Extended
Oversold | Overbought |
Using GeneDx Holdings hype-based prediction, you can estimate the value of GeneDx Holdings Corp from the perspective of GeneDx Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of GeneDx Holdings Corp on the next trading day is expected to be 104.88 with a mean absolute deviation of 3.37 and the sum of the absolute errors of 205.71. GeneDx Holdings after-hype prediction price | USD 104.88 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of GeneDx Holdings to cross-verify your projections. GeneDx Holdings Additional Predictive Modules
Most predictive techniques to examine GeneDx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for GeneDx using various technical indicators. When you analyze GeneDx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
GeneDx Holdings Simple Exponential Smoothing Price Forecast For the 28th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of GeneDx Holdings Corp on the next trading day is expected to be 104.88 with a mean absolute deviation of 3.37, mean absolute percentage error of 22.63, and the sum of the absolute errors of 205.71.Please note that although there have been many attempts to predict GeneDx Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that GeneDx Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
GeneDx Holdings Stock Forecast Pattern
| Backtest GeneDx Holdings | GeneDx Holdings Price Prediction | Buy or Sell Advice |
GeneDx Holdings Forecasted Value
In the context of forecasting GeneDx Holdings' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. GeneDx Holdings' downside and upside margins for the forecasting period are 101.32 and 108.44, respectively. We have considered GeneDx Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of GeneDx Holdings stock data series using in forecasting. Note that when a statistical model is used to represent GeneDx Holdings stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.2298 |
| Bias | Arithmetic mean of the errors | 0.5343 |
| MAD | Mean absolute deviation | 3.3723 |
| MAPE | Mean absolute percentage error | 0.0254 |
| SAE | Sum of the absolute errors | 205.71 |
Predictive Modules for GeneDx Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as GeneDx Holdings Corp. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.GeneDx Holdings After-Hype Price Density Analysis
As far as predicting the price of GeneDx Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in GeneDx Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of GeneDx Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
GeneDx Holdings Estimiated After-Hype Price Volatility
In the context of predicting GeneDx Holdings' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on GeneDx Holdings' historical news coverage. GeneDx Holdings' after-hype downside and upside margins for the prediction period are 101.31 and 108.45, respectively. We have considered GeneDx Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
GeneDx Holdings is very steady at this time. Analysis and calculation of next after-hype price of GeneDx Holdings Corp is based on 3 months time horizon.
GeneDx Holdings Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as GeneDx Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GeneDx Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with GeneDx Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 3.56 | 0.43 | 0.15 | 3 Events / Month | 7 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
104.88 | 104.88 | 0.00 |
|
GeneDx Holdings Hype Timeline
On the 27th of January GeneDx Holdings Corp is traded for 104.88. The entity has historical hype elasticity of 0.43, and average elasticity to hype of competition of 0.15. GeneDx is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at -0.32%. %. The volatility of related hype on GeneDx Holdings is about 768.9%, with the expected price after the next announcement by competition of 105.03. About 12.0% of the company outstanding shares are owned by insiders. The company had not issued any dividends in recent years. GeneDx Holdings Corp had 1:33 split on the 4th of May 2023. Considering the 90-day investment horizon the next forecasted press release will be in about 3 days. Check out Historical Fundamental Analysis of GeneDx Holdings to cross-verify your projections.GeneDx Holdings Related Hype Analysis
Having access to credible news sources related to GeneDx Holdings' direct competition is more important than ever and may enhance your ability to predict GeneDx Holdings' future price movements. Getting to know how GeneDx Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how GeneDx Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HNGE | Hinge Health | 1.33 | 11 per month | 0.00 | (0.11) | 4.16 | (3.95) | 21.22 | |
| KYMR | Kymera Therapeutics | 1.27 | 7 per month | 2.74 | 0.06 | 4.40 | (4.46) | 49.42 | |
| TMDX | TransMedics Group | 0.90 | 12 per month | 2.58 | 0.01 | 5.74 | (5.18) | 21.24 | |
| VKTX | Viking Therapeutics | (2.48) | 11 per month | 3.42 | (0.02) | 7.96 | (5.49) | 19.06 | |
| OSCR | Oscar Health | 0.00 | 0 per month | 0.00 | (0.06) | 7.00 | (7.46) | 30.41 | |
| IMVT | Immunovant | 0.68 | 11 per month | 2.08 | 0.14 | 5.31 | (3.63) | 20.44 | |
| PRVA | Privia Health Group | (0.56) | 7 per month | 0.00 | (0.12) | 2.90 | (2.59) | 9.62 | |
| CRNX | Crinetics Pharmaceuticals | 2.10 | 9 per month | 2.43 | 0.08 | 4.38 | (5.14) | 19.30 | |
| OPCH | Option Care Health | 1.33 | 16 per month | 1.64 | 0.16 | 4.34 | (1.80) | 10.25 | |
| NAMS | NewAmsterdam Pharma | 0.06 | 6 per month | 0.00 | (0.07) | 4.72 | (4.89) | 15.37 |
Other Forecasting Options for GeneDx Holdings
For every potential investor in GeneDx, whether a beginner or expert, GeneDx Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GeneDx Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GeneDx. Basic forecasting techniques help filter out the noise by identifying GeneDx Holdings' price trends.GeneDx Holdings Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with GeneDx Holdings stock to make a market-neutral strategy. Peer analysis of GeneDx Holdings could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
GeneDx Holdings Market Strength Events
Market strength indicators help investors to evaluate how GeneDx Holdings stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GeneDx Holdings shares will generate the highest return on investment. By undertsting and applying GeneDx Holdings stock market strength indicators, traders can identify GeneDx Holdings Corp entry and exit signals to maximize returns.
GeneDx Holdings Risk Indicators
The analysis of GeneDx Holdings' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GeneDx Holdings' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting genedx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.51 | |||
| Standard Deviation | 3.57 | |||
| Variance | 12.73 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for GeneDx Holdings
The number of cover stories for GeneDx Holdings depends on current market conditions and GeneDx Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that GeneDx Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about GeneDx Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
GeneDx Holdings Short Properties
GeneDx Holdings' future price predictability will typically decrease when GeneDx Holdings' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of GeneDx Holdings Corp often depends not only on the future outlook of the potential GeneDx Holdings' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. GeneDx Holdings' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.9 M | |
| Cash And Short Term Investments | 141.2 M |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.